Management Guidance

Management acknowledges a current transitional phase marked by significant losses and declining consumer revenue, expecting these headwinds to persist for a maximum of two more quarters. The long-term strategy hinges on aggressive expansion of the enterprise vertical, which is projected to account for 80-90% of revenue within two to three years, driven by new offerings like EDR, XDR, and data privacy solutions. While specific revenue targets are not disclosed, the company expresses confidence in its ability to navigate the current challenges and maintain leadership in the consumer segment, supported by a debt-free balance sheet and ongoing investments in R&D and market expansion.

Management Guidance

Management indicated a challenging near-term outlook for FY27 due to ongoing regulatory changes, energy efficiency upgrades, and geopolitical impacts on supply chains. However, for the base business (refrigerators and washers), they aim for high single-digit to early double-digit CAGR growth over the long run. Margins are expected to stabilize in the high single-digit range for the core business, while Elica is projected to maintain double-digit margins, with a focus on reinvesting some profits for growth. The company is actively evaluating strategic investments in product innovation, automation, factory optimization, and potential adjacent category acquisitions, while currently deprioritizing buybacks in favor of long-term value creation through business expansion.

Management Guidance

Management expects Q1 FY27 to reflect trends seen in Q4 FY26, with muted corporate gifting orders and continued impact from the geopolitical environment on export demand. They anticipate these headwinds to progressively ease over the course of the year. While formal guidance for FY27 is deferred to allow for better visibility, the company is investing in brand relevance, distribution, category expansion, and operational efficiencies, supported by steady progress in international initiatives and joint ventures, positioning for sustainable growth over the medium to long term.

Management Guidance

Management anticipates improved realizations and increased volumes for vanillin in upcoming quarters, driven by reduced tariffs and increased ethyl vanillin production. The Blends business is projected for strong growth, aiming for INR1,400 crores in FY27. While acknowledging near-term challenges from geopolitical conflicts impacting freight costs and raw material availability, the company expects these to stabilize over the next quarter. Overall, the company guides for FY27 revenue between INR2,200-2,400 crores with EBITDA margins of 12-14%.

Management Guidance

Management provided limited forward-looking guidance due to current market uncertainties, specifically mentioning the geopolitical situation and rising costs. They are committed to improving performance and are on a growth path, expecting to be in a better position to provide guidance after the first quarter. While revenue and EBITDA growth are anticipated, specific quantitative targets for FY27-28 were withheld. The company's strategic direction remains focused on an asset-light model, expanding its managed and revenue share properties, and integrating technology and AI. Capital expenditure is expected to be modest, primarily for maintenance and renovation, with strong internal cash reserves to fund planned growth.

Management Guidance

Divi's Laboratories anticipates continued double-digit revenue growth in the medium to long term. Management expressed confidence in maintaining stable profitability despite current cost pressures, aiming to offset increases through pricing discussions and operational efficiencies. While specific timelines for dedicated capacity utilization remain subject to customer regulatory approvals, the company is investing ahead of anticipated future demand and aims for consistent capital expenditure, maintaining its strategic focus on expanding capabilities in custom synthesis and peptides.

Management Guidance

Management anticipates short-term challenges related to inventory and market adjustments, but remains committed to a long-term revenue growth target of 15-20% year-on-year. They aim to achieve EBITDA margins closer to 20% in the medium term. Significant capex is planned for new manufacturing facilities, including vacuum-insulated stainless steel products and expanded glassware production, expected to enhance cost efficiency and product diversification. The company expects solar plant commissioning in Q1 FY27 to contribute to cost savings. Guidance for FY27 capex is around INR110 crores.

Management Guidance

Management highlighted strong Q4 performance driven by both distribution and manufacturing segments, with revenue up 38% and EBITDA up 90%. The company expects continued revenue growth in the upcoming year, driven by new product additions and expanding end-user customer bases in both distribution and manufacturing. While near-term demand in distribution is anticipated to remain subdued due to global uncertainties, higher pricing should drive revenue upwards, and merchant exports show a strong order pipeline. Manufacturing outlook is positive with picking export demand for acrylamide and steady performance in acrylamide solid. The company is progressing on its PAM solid project and developing new downstream products, with a potential decision on the Specialty amines project this year, all expected to add to the top line and revenues in future quarters.

Management Guidance

Management forecasts a minimum of 25% revenue growth for FY27, supported by a strong order book of INR1202 crores (including L1 orders) and channel business. They expect EBITDA margins to remain in the 12-13% range, with PAT margins between 8.5% and 9.5%. The company anticipates operating cash flow to turn positive in FY27, with receivables targeted at 120-150 days. Strategic initiatives include the commissioning of new manufacturing facilities in Jhajjar and Gujarat, enhancing production capacity and market reach. The company also plans to hive off BESS developer projects, focusing on EPC execution.

Management Guidance

Management provided guidance on planned capex of INR200-300 crores over the next two to three years, with expected fixed asset turnover of 1 to 1.5 times and ROI of 15-20%. They anticipate enhanced value and margin accretion from new business coming online, particularly in Performance Solutions, contract manufacturing, and YP derivatives, which are identified as key growth areas. While specific revenue targets were not disclosed, there's a strategic intent to increase exports and the proportion of contract manufacturing in the overall portfolio. The company plans to launch another biocide product in the second half of the current financial year.